A 37-year-old woman’s experience underscores a concerning trend: the increasing incidence of rectal cancer in younger adults, accompanied by rising death rates and a critical need for heightened symptom awareness.

A Delayed Diagnosis

Ashleigh Wolsey, a logistics worker, initially attributed changes in her bowel habits to a recurrence of irritable bowel syndrome (IBS) she had as a teenager. She experienced alternating periods of constipation and frequent, incomplete bowel movements, often with pain.

A significant amount of blood in the toilet during a flight to Madrid prompted her to seek medical attention. Initial blood tests and a FIT (fecal immunochemical test) for trace blood were inconclusive, and doctors initially diagnosed her symptoms as IBS.

Persistent Symptoms Lead to Colonoscopy

However, Ashleigh persisted, citing her father’s death from stomach cancer at age 55. This led to a referral for a colonoscopy, which revealed a 1.5-inch tumor in her rectum. She was later diagnosed with stage three rectal cancer, indicating the cancer had spread to nearby lymph nodes.

A Growing Trend

Ashleigh’s case is part of a broader, alarming trend. While bowel cancer rates are declining in older adults due to increased screening, diagnoses are steadily increasing in individuals under 45.

Research from the US indicates that deaths from rectal cancer in this age group are rising up to three times faster than deaths from colon cancer. Researchers predict this trend will continue for at least another decade, identifying rectal cancer as a major driver of the early-onset bowel cancer epidemic.

Understanding Rectal Cancer

Experts emphasize that colorectal cancer is no longer limited to older adults, and early action is vital to reverse this trend. Approximately 16,000 people in Britain are diagnosed with rectal cancer annually, which develops in the final section of the large bowel.

Challenges in Early Detection

Detecting rectal cancer early is challenging because its symptoms often mimic those of less serious conditions like IBS. This leads to diagnostic delays, with up to three in four younger patients diagnosed only after the cancer has already spread.

Early detection significantly improves survival rates: 91% within five years when the cancer is confined to the bowel, 74% with nearby spread, and only 13% with distant metastasis.

Key Symptoms to Watch For

Key symptoms include blood in stool, abdominal pain, changes in bowel habits, iron deficiency, unexplained weight loss, and bloating or pain after eating. Being vigilant about these symptoms and seeking prompt medical evaluation is crucial, even without known risk factors.

Three-quarters of new colon cancer cases occur in patients with no known risk factors, further emphasizing the importance of awareness and early screening.